2026 International Fall Summit
October 28, 2026 | 12:00 PM EST
S10 E11: Your Best Meeting Ever
Published Date:
Share
With podcast host, Ginger Blackmon, and featuring Rebecca Hinds, PhD
What if meetings were designed with the same level of intention as patient care?
In this episode, we’re joined by Rebecca Hinds, PhD, organizational behavior expert and author of Your Best Meeting Ever, for a conversation on how teams can rethink the way they meet, collaborate, and communicate in today’s increasingly complex work environment.
Drawing from her research at Asana and Glean, Rebecca shares why meetings should be treated like products — designed around the people in the room, not just the agenda. Together, we explore practical strategies that feel especially relevant for multidisciplinary oncology teams, including meeting minimalism, “no spectators, only stakeholders,” stronger meeting starts, and how small shifts in structure can create more engaged and effective collaboration.
The conversation also dives into the role of AI and “calm technology” in healthcare settings, balancing efficiency with the human connection that remains essential to patient-centered care.
At its core, the episode is less about meetings themselves and more about how intentional collaboration can improve the way teams work together.
Learn more about Rebecca and her work here.
Recent Episodes
S10 E9: Bringing Clinical Trials Closer to Patients
John Burke, MD, shares what it actually takes to build and sustain clinical research in a community oncology setting—from real-world barriers to how practices are working to make it part of everyday care.
April 21, 2026
S10 E8: TheOncDoc on AI: What Actually Matters for Oncology Teams
This episode explores how AI is being applied in oncology care today, featuring insights from Dr. Sanjay Juneja on integrating AI into workflows, supporting patient education, and navigating real-world use in clinical practice.
April 8, 2026
S10 E7: Scaling Hope: The Future of Cell Therapy Access
In this episode of the PQI Podcast, Fabian Gerlinghaus, Co-founder and CEO of Cellares, shares insights into the evolving landscape of cell therapy manufacturing and its impact on patient access.
April 1, 2026